is tirzepatide for type 2 diabetes monotherapy in Chinese patients with early diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO) Understanding Mounjaro: A Guide for

The liquid form allows for better absorption, ensuring optimal effectiveness

The insulin receptor: a new target for cancer therapy

The MHRA is the medicines regulator for the whole of the United Kingdom, including Northern Ireland, following the implementation of the Windsor Framework for medicines (from 1 January 2025)

Receptors & Channels

Participants with BMI change outside the ranges for these cohorts, participants with malignant cancer or thyroid disorder before the start of follow-up, and those with a record of pregnancy or limb amputation during the baseline period were excluded to ensure no unintentional weight loss